Bioengineered bacteria-derived outer membrane vesicles as a versatile antigen display platform for tumor vaccination via Plug-and-Display technology
Plug and play
Spark plug
DOI:
10.1038/s41467-021-22308-8
Publication Date:
2021-04-06T10:02:48Z
AUTHORS (19)
ABSTRACT
An effective tumor vaccine vector that can rapidly display neoantigens is urgently needed. Outer membrane vesicles (OMVs) strongly activate the innate immune system and are qualified as immunoadjuvants. Here, we describe a versatile OMV-based platform to elicit specific anti-tumor response via specifically presenting antigens onto OMV surface. We first on OMVs surface by fusing with ClyA protein, then simplify antigen process employing Plug-and-Display comprising tag/catcher protein pairs. decorated different catchers simultaneously multiple, distinct synergistic antitumour response. In addition, bioengineered loaded abrogate lung melanoma metastasis inhibit subcutaneous colorectal cancer growth. The ability of may facilitate development these agents for personalized tumour vaccines.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (51)
CITATIONS (313)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....